AN EXPERIMENTAL MODEL FOR EVALUATION OF GLUCOSE TOLERANCE IN RABBIT

I. PENCHEV GEORGIEV, I. N. KANELOV, S. S. DIMITROVA, Y. I. ILIEV, S. I. TANEV, T. M. GEORGIEVA, B. L. BIVOLARSKI, E. G. VACHKOVA & I. I. GRIGOROV Department of Pharmacology, Animal Physiology and Physiological Chemistry, Faculty of Veterinary Medicine, Trakia University; Stara Zagora, Bulgaria; Vitesse Re-Skilling Canada Photonics and Biophotonics Programs, 349 Terry Fox Drive, Kanata, Ontario, Canada, Department of Animal Husbandry, Non-ruminant and Other Animals, Agricultural Faculty, Trakia University; Stara Zagora, Bulgaria

[1]  A. Marzo.  Open questions on bioequivalence: some problems and some solutions. , 1999, Pharmacological research.

[2]  L. Mandarino,et al.  Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. , 1982, The Journal of clinical endocrinology and metabolism.

[3]  G. Bottoms,et al.  Glucose tolerance and insulin response in normal-weight and obese cats. , 1990, American journal of veterinary research.

[4]  F. Faas,et al.  Spontaneous diabetes mellitus in the New Zealand white rabbit: physiologic characteristics. , 1981, Metabolism: clinical and experimental.

[5]  M. Hoenig,et al.  Influence of glucose dosage on interpretation of intravenous glucose tolerance tests in lean and obese cats. , 2002, Journal of veterinary internal medicine.

[6]  M. Martinez,et al.  Noncompartmental methods of drug characterization: statistical moment theory. , 1998, Journal of the American Veterinary Medical Association.

[7]  M. Hussain,et al.  Beta-cell apoptosis in the pathogenesis of human type 2 diabetes mellitus. , 2003, European journal of endocrinology.

[8]  R. Robertson,et al.  Minireview: Secondary β-Cell Failure in Type 2 Diabetes-A Convergence of Glucotoxicity and Lipotoxicity. , 2002, Endocrinology.

[9]  A. Garjani,et al.  Enhancing dissolution, serum concentrations and hypoglycemic effect of glibenclamide using solvent deposition technique. , 2005, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[10]  F. Ashcroft,et al.  A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice , 2005, Diabetologia.

[11]  A. Goldfine,et al.  The cellular fate of glucose and its relevance in type 2 diabetes. , 2004, Endocrine reviews.

[12]  W. Bolton,et al.  Somatostatin secretion in diabetic rabbits. , 1982, Metabolism: clinical and experimental.

[13]  D. Legros,et al.  The intravenous insulin tolerance test in the dog: experimental study [IVTTI] , 2001 .

[14]  M. Stumvoll,et al.  Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. , 2000, Diabetes care.

[15]  R. Rizza,et al.  Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. , 1980, The Journal of clinical investigation.

[16]  Jim E. Riviere,et al.  Comparative Pharmacokinetics: Principles, Techniques, and Applications , 1999 .

[17]  D. Panciera,et al.  Epizootiologic patterns of diabetes mellitus in cats: 333 cases (1980-1986). , 1990, Journal of the American Veterinary Medical Association.

[18]  D. W. Hayden,et al.  High Dose Intravenous Glucose Tolerance Test and Serum Insulin and Glucagon Levels in Diabetic and Non-diabetic Cats: Relationships to Insular Amyloidosis , 1985, Veterinary pathology.

[19]  T. Lutz,et al.  Effects of high carbohydrate and high fat diet on plasma metabolite levels and on iv glucose tolerance test in intact and neutered male cats , 2004, Journal of feline medicine and surgery.

[20]  N. Schneiderman,et al.  Effect of Behavioral Interventions on Insulin Sensitivity and Atherosclerosis in the Watanabe Heritable Hyperlipidemic Rabbit , 2005, Psychosomatic medicine.

[21]  K. Polonsky,et al.  Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals. , 1997, The Journal of clinical endocrinology and metabolism.

[22]  J. Rand,et al.  Evaluation of a simplified intravenous glucose tolerance test and a reflectance glucose meter for use in cats , 1997, Veterinary Record.

[23]  J. Habener,et al.  Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4. , 2004, Diabetes.

[24]  R. Chandra,et al.  Hypoglycemic and antidiabetic effect of ethanolic extract of leaves of Annona squamosa L. in experimental animals. , 2005, Journal of ethnopharmacology.

[25]  C. Bogardus,et al.  The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. , 1999, The Journal of clinical investigation.

[26]  A. Saltiel.  Putting the brakes on insulin signaling. , 2003, The New England journal of medicine.

[27]  K. Polonsky,et al.  Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. , 2000, The Journal of clinical investigation.

[28]  M. Gibaldi.  Compartmental and Noncompartmental Pharmacokinetics 2 14 Gastrointestinal Absorption — Biologic Considerations 24 Gastrointestinal Absorption — Physicochemical Considerations , 2022 .

[29]  A. Al-Hader,et al.  Hyperglycemic and insulin release inhibitory effects of Rosmarinus officinalis. , 1994, Journal of ethnopharmacology.

[30]  C. Brown,et al.  Spontaneous diabetes mellitus in the New Zealand white rabbit: history, classification, and genetic analysis. , 1980, The Journal of heredity.

[31]  L. Fleeman,et al.  Canine and feline diabetes mellitus: nature or nurture? , 2004, The Journal of nutrition.